Henry Schein, Inc. (NASDAQ:HSIC) was downgraded by equities research analysts at BidaskClub from a “hold” rating to a “sell” rating in a research report issued on Wednesday.
HSIC has been the topic of a number of other research reports. Stifel Nicolaus boosted their price target on shares of Henry Schein from $174.00 to $178.00 and gave the company a “hold” rating in a report on Wednesday, May 10th. Zacks Investment Research upgraded shares of Henry Schein from a “hold” rating to a “buy” rating and set a $204.00 price objective on the stock in a research note on Thursday, May 25th. Piper Jaffray Companies began coverage on shares of Henry Schein in a research note on Monday, June 12th. They issued a “neutral” rating and a $200.00 price objective on the stock. Credit Suisse Group reiterated a “hold” rating and issued a $160.00 price objective on shares of Henry Schein in a research note on Thursday, July 13th. Finally, Craig Hallum began coverage on shares of Henry Schein in a research note on Tuesday, April 11th. They issued a “hold” rating on the stock. One investment analyst has rated the stock with a sell rating, eleven have assigned a hold rating and six have issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average target price of $183.40.
Henry Schein (HSIC) traded down 1.09% during trading on Wednesday, reaching $179.30. The company had a trading volume of 432,476 shares. The company has a market capitalization of $14.22 billion, a PE ratio of 27.25 and a beta of 1.09. Henry Schein has a 52-week low of $146.23 and a 52-week high of $186.99. The stock has a 50 day moving average price of $183.44 and a 200-day moving average price of $174.47.
Henry Schein (NASDAQ:HSIC) last released its quarterly earnings results on Tuesday, May 9th. The company reported $1.76 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.65 by $0.11. Henry Schein had a net margin of 4.53% and a return on equity of 19.74%. The business had revenue of $2.92 billion for the quarter, compared to analyst estimates of $2.83 billion. During the same quarter in the previous year, the business earned $1.41 earnings per share. The firm’s revenue was up 7.7% compared to the same quarter last year. On average, equities research analysts anticipate that Henry Schein will post $7.28 earnings per share for the current fiscal year.
COPYRIGHT VIOLATION WARNING: “Henry Schein, Inc. (NASDAQ:HSIC) Downgraded to Sell at BidaskClub” was originally reported by StockNewsTimes and is the sole property of of StockNewsTimes. If you are accessing this story on another domain, it was illegally stolen and reposted in violation of United States and international trademark and copyright legislation. The original version of this story can be accessed at https://stocknewstimes.com/2017/08/02/henry-schein-inc-nasdaqhsic-downgraded-to-sell-at-bidaskclub.html.
In other news, EVP Gerald A. Benjamin sold 12,578 shares of the stock in a transaction on Thursday, May 11th. The shares were sold at an average price of $175.10, for a total transaction of $2,202,407.80. Following the transaction, the executive vice president now owns 44,061 shares in the company, valued at approximately $7,715,081.10. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Corporate insiders own 1.27% of the company’s stock.
Hedge funds and other institutional investors have recently made changes to their positions in the company. Thrivent Financial for Lutherans raised its position in shares of Henry Schein by 4.9% in the fourth quarter. Thrivent Financial for Lutherans now owns 2,810 shares of the company’s stock valued at $426,000 after buying an additional 130 shares during the period. Quadrature Capital Ltd acquired a new position in shares of Henry Schein during the fourth quarter valued at approximately $1,140,000. Kentucky Retirement Systems acquired a new position in shares of Henry Schein during the fourth quarter valued at approximately $886,000. Kentucky Retirement Systems Insurance Trust Fund acquired a new position in shares of Henry Schein during the fourth quarter valued at approximately $395,000. Finally, Macquarie Group Ltd. raised its position in shares of Henry Schein by 84.0% in the fourth quarter. Macquarie Group Ltd. now owns 4,600 shares of the company’s stock valued at $698,000 after buying an additional 2,100 shares during the period. Institutional investors own 90.84% of the company’s stock.
About Henry Schein
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
